Japan’s MHLW Demands Additional Information On Side Effects Regarding 13 Components
This article was originally published in PharmAsia News
Executive Summary
Japan`s MHLW sent a notification to the Federation of Pharmaceutical Manufacturers' Associations of Japan requesting the revision of package inserts for 13 components.